JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32508

Anti-AMPK gamma 1 antibody [Y308]

5

(7 Reviews)

|

(27 Publications)

Rabbit Recombinant Monoclonal AMPK gamma 1 antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 27 publications.

View Alternative Names

5'-AMP-activated protein kinase subunit gamma-1, AMPK gamma1, AMPK subunit gamma-1, AMPKg, PRKAG1

7 Images
Flow Cytometry (Intracellular) - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-AMPK gamma 1 antibody [Y308] (AB32508)

Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling AMPK gamma 1 with ab32508 at 1/100 dilution (1μg) (Red). Goat anti rabbit IgG (Alexa Fluor®488, ab150077) at 1/2000 dilution was used as the secondary antibody. Cells were fixed with4% paraformaldehyde. Rabbit monoclonal IgG (ab172730) was used as isotype control (Black). Unlabelled control : Cells without incubation with primary antibody and secondary antibody (Blue).

Immunoprecipitation - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
  • IP

Lab

Immunoprecipitation - Anti-AMPK gamma 1 antibody [Y308] (AB32508)

AMPK gamma 1 was immunoprecipitated using 1 mg Jurkat whole cell extract, 0.2 ug of Rabbit monoclonal [Y308] to AMPK gamma 1and 50μl of protein G magnetic beads (lane 1). The antibody was incubated with the Protein G beads for 10min under agitation. No antibody was added to the control (lane 2). Jurkat whole cell extractdiluted in RIPA buffer was added to each sample and incubated for 10min under agitation. Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70oC; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab32508. Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697). Bands : 37kDa : AMPK gamma 1.

All lanes:

Immunoprecipitation - Anti-AMPK gamma 1 antibody [Y308] (ab32508)

Predicted band size: 38 kDa

false

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
  • WB

AbReview39625****

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)

All lanes:

Western blot - Anti-AMPK gamma 1 antibody [Y308] (ab32508) at 1/1000 dilution

All lanes:

HEK293 whole cell lysate at 30 µg

Secondary

All lanes:

Alexa Fluor® 690-conjugated Goat anti-rabbit IgG polyclonal at 1/10000 dilution

Predicted band size: 38 kDa

Observed band size: 38 kDa

false

Exposure time: 5min

This image is courtesy of an anonymous Abreview

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
  • WB

Unknown

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)

All lanes:

Western blot - Anti-AMPK gamma 1 antibody [Y308] (ab32508) at 1/1000 dilution

All lanes:

Jurkat cell lysate

Predicted band size: 38 kDa

Observed band size: 38 kDa

false

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
  • WB

CiteAb

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)

Western Blotting using Anti-AMPK gamma 1 antibody [Y308], ab32508. Publication image from Yan, Z. et al., 2017, Nat Commun, 28916822. Legend direct from paper.

Ampk, Ulk1 and Drp1, are transiently activated immediately following acute exercise. Ampk and its substrate Acc are phosphorylated at Thr172 a, b and S79 a, c, respectively, immediately after the cessation of exercise and return to baseline values by 3 h post-exercise in C57BL/6 J mice aged 10–12 weeks. Ulk1 is phosphorylated at Ser555, but not Ser467 or Ser757, immediately following acute exercise, which returns to basal levels by 3 h post-exercise a, d–f. Drp1 is phosphorylated in skeletal muscle at Ser616 a, g immediately after the cessation of exercise and Ser637 a, h reaching significance 3 and 6 h after exercise. Mfn2 protein abundance is unchanged following acute treadmill running a, i. Representative western blots are shown a and all quantification is presented as protein phosphorylation to total protein abundance ratio b–f. Data presented as mean ± standard error of the mean. n = 5 (except 24 h, n = 4). See also Supplementary Figs. 6 and 7. Results of one-way ANOVAs are *p < 0.05, **p < 0.01. F = 6.44 for b, F = 3.56 for c, F = 6.50 for d, F = 0.89 for e, F = 0.33 for f, F = 3.34 for g, F = 2.76 for h, F = 0.31 i. DF = 5. p-Ampk (T172/Total) b was sqrt transformed to account for unequal variance., DF = 5. S637/total Drp1 data was log transformed to account for unequal variance

false

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
  • WB

CiteAb

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)

Western Blotting using Anti-AMPK gamma 1 antibody [Y308], ab32508. Publication image from Yan, Z. et al., 2017, Nat Commun, 28916822. Legend direct from paper.

Ampk is necessary and sufficient for phosphorylation of Ulk1 at Ser555 in response to acute exercise. Phosphorylation of Ampk at T172 in response to acute exercise is blocked in Ampk dnTG a, b, whereas increased phosphorylation of Acc at Ser79 post-exercise is still observed a, c. In Ampk caTG mice, both T172 Ampk and S79 Acc are elevated in sedentary conditions f–h. Phosphorylation of Ulk1 at Ser555 is blunted in dnTG skeletal muscle immediately after acute exercise a, d but elevated in caTG mice basally f, i. There was no effect on S757 phosphorylation in either dnTG mice post exercise a, e or sedentary caTG mice (f, j). Representative western blots are shown for dnTG mice a and caTG mice f. See also Supplementary Figs. 8 and 9. All quantification is presented as protein phosphorylation to total protein abundance ratio b–e, g–j. Data are presented as mean ± standard error of the mean. For dnTG study n = 10 WT or 5–7 dnTG (12–13 weeks). Results of two-way ANOVAs are *p < 0.05, **p < 0.01 for sedentary vs. exercise comparisons, F = 4.57 and DF = 1 c. ###p < 0.001 for between group comparisons, F = 14.03 and DF = 1 (e). Tukey multiple comparison tests were performed when a significant interaction effect was observed, in which *p < 0.05, **p < 0.01 for WT sedentary vs. WT exercise comparisons and $$p < 0.01, $$$p < 0.001 for WT exercise vs. dnTG exercise comparisons, DF = 27. For caTG study n = 3 (WT) or 5 (caTG) (13–15 weeks). Results of two-tailed t-tests are *p < 0.05 and **p < 0.01 for WT to caTG comparisons, t = 4.94 (g), t = 2.57 (h), t = 2.71 (i), t = 1.72 (j), DF = 6

false

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
  • WB

CiteAb

Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)

Western Blotting using Anti-AMPK gamma 1 antibody [Y308], ab32508. Publication image from Yan, Z. et al., 2017, Nat Commun, 28916822. Legend direct from paper.

Ampk is necessary and sufficient for phosphorylation of Ulk1 at Ser555 in response to acute exercise. Phosphorylation of Ampk at T172 in response to acute exercise is blocked in Ampk dnTG a, b, whereas increased phosphorylation of Acc at Ser79 post-exercise is still observed a, c. In Ampk caTG mice, both T172 Ampk and S79 Acc are elevated in sedentary conditions f–h. Phosphorylation of Ulk1 at Ser555 is blunted in dnTG skeletal muscle immediately after acute exercise a, d but elevated in caTG mice basally f, i. There was no effect on S757 phosphorylation in either dnTG mice post exercise a, e or sedentary caTG mice (f, j). Representative western blots are shown for dnTG mice a and caTG mice f. See also Supplementary Figs. 8 and 9. All quantification is presented as protein phosphorylation to total protein abundance ratio b–e, g–j. Data are presented as mean ± standard error of the mean. For dnTG study n = 10 WT or 5–7 dnTG (12–13 weeks). Results of two-way ANOVAs are *p < 0.05, **p < 0.01 for sedentary vs. exercise comparisons, F = 4.57 and DF = 1 c. ###p < 0.001 for between group comparisons, F = 14.03 and DF = 1 (e). Tukey multiple comparison tests were performed when a significant interaction effect was observed, in which *p < 0.05, **p < 0.01 for WT sedentary vs. WT exercise comparisons and $$p < 0.01, $$$p < 0.001 for WT exercise vs. dnTG exercise comparisons, DF = 27. For caTG study n = 3 (WT) or 5 (caTG) (13–15 weeks). Results of two-tailed t-tests are *p < 0.05 and **p < 0.01 for WT to caTG comparisons, t = 4.94 (g), t = 2.57 (h), t = 2.71 (i), t = 1.72 (j), DF = 6

false

  • Carrier free

    Anti-AMPK gamma 1 antibody [Y308] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

Y308

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, Flow Cyt (Intra), IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody recognises 5'-AMP-activated protein kinase (AMPK).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "IHC" : {"fullname" : "Immunohistochemistry", "shortname":"IHC"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "IHC-species-checked": "notRecommended", "IHC-species-dilution-info": "", "IHC-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/100", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "IHC-species-checked": "notRecommended", "IHC-species-dilution-info": "", "IHC-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "IHC-species-checked": "notRecommended", "IHC-species-dilution-info": "", "IHC-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "African green monkey": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "IHC-species-checked": "notRecommended", "IHC-species-dilution-info": "", "IHC-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism (PubMed : 21680840, PubMed : 24563466). In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes : inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation (PubMed : 21680840, PubMed : 24563466). AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators (PubMed : 21680840, PubMed : 24563466). Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin (PubMed : 21680840, PubMed : 24563466). Gamma non-catalytic subunit mediates binding to AMP, ADP and ATP, leading to activate or inhibit AMPK : AMP-binding results in allosteric activation of alpha catalytic subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and preventing dephosphorylation of catalytic subunits (PubMed : 21680840, PubMed : 24563466). ADP also stimulates phosphorylation, without stimulating already phosphorylated catalytic subunit (PubMed : 21680840, PubMed : 24563466). ATP promotes dephosphorylation of catalytic subunit, rendering the AMPK enzyme inactive (PubMed : 21680840, PubMed : 24563466).
See full target information PRKAG1

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

Nature 633:189-197 PubMed39143206

2024

Remodelling of the translatome controls diet and its impact on tumorigenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Haojun Yang,Vincenzo Andrea Zingaro,James Lincoff,Harrison Tom,Satoshi Oikawa,Juan A Oses-Prieto,Quinn Edmondson,Ian Seiple,Hardik Shah,Shingo Kajimura,Alma L Burlingame,Michael Grabe,Davide Ruggero

iScience 27:108852 PubMed38303706

2024

Ultrasound-targeted microbubble technology facilitates SAHH gene delivery to treat diabetic cardiomyopathy by activating AMPK pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaohui Guo,Kegong Chen,Lin Ji,Shanjie Wang,Xiangmei Ye,Liang Xu,Leiguang Feng

Cell chemical biology 30:1585-1600.e6 PubMed37890479

2023

Blocking AMPKαS496 phosphorylation improves mitochondrial dynamics and hyperglycemia in aging and obesity.

Applications

Unspecified application

Species

Unspecified reactive species

Alexia Pearah,Balamurugan Ramatchandirin,Ting Liu,Risa M Wolf,Arisa Ikeda,Sally Radovick,Hiromi Sesaki,Fredric E Wondisford,Brian O'Rourke,Ling He

The Journal of biological chemistry 298:101852 PubMed35331736

2022

Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite-binding site.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew J Sanders,Yann Ratinaud,Katyayanee Neopane,Nicolas Bonhoure,Emily A Day,Olivier Ciclet,Steve Lassueur,Martine Naranjo Pinta,Maria Deak,Benjamin Brinon,Stefan Christen,Gregory R Steinberg,Denis Barron,Kei Sakamoto

Aging 13:16834-16858 PubMed34166224

2021

The consequences of a high-calorie diet background before calorie restriction on skeletal muscles in a mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Martin Maldonado,Jianying Chen,Yang Lujun,Huiqin Duan,Mazhar Ali Raja,Ting Qu,Tianhua Huang,Jiang Gu,Ying Zhong

Pharmaceuticals (Basel, Switzerland) 14: PubMed34073624

2021

Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4 Protein Degradation Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Seung-Joo Yang,Seungje Jeon,Jeong Won Baek,Kwang Min Lee,Chul-Seung Park

Frontiers in pharmacology 12:630210 PubMed33841151

2021

Jian-Pi-Yi-Shen Formula Ameliorates Oxidative Stress, Inflammation, and Apoptosis by Activating the Nrf2 Signaling in 5/6 Nephrectomized Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Fanyuan Zhou,Xiaohu Zou,Jing Zhang,Ziwei Wang,Yajun Yang,Dongtao Wang

Molecular metabolism :101183 PubMed33548500

2021

Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis.

Applications

Unspecified application

Species

Unspecified reactive species

Séverine Olivier,Camille Pochard,Hanna Diounou,Vanessa Castillo,Jordane Divoux,Joshua Alcantara,Jocelyne Leclerc,Sandra Guilmeau,Camille Huet,Wafa Charifi,Thibault V Varin,Noëmie Daniel,Marc Foretz,Michel Neunlist,Benoit L Salomon,Pradipta Ghosh,André Marette,Malvyne Rolli-Derkinderen,Benoit Viollet

Molecular therapy : the journal of the American So 28:1133-1153 PubMed32087766

2020

AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Hiroya Ono,Naoki Suzuki,Shin-Ichiro Kanno,Genri Kawahara,Rumiko Izumi,Toshiaki Takahashi,Yasuo Kitajima,Shion Osana,Naoko Nakamura,Tetsuya Akiyama,Kensuke Ikeda,Tomomi Shijo,Shio Mitsuzawa,Ryoichi Nagatomi,Nobukazu Araki,Akira Yasui,Hitoshi Warita,Yukiko K Hayashi,Katsuya Miyake,Masashi Aoki

Cell death & disease 11:115 PubMed32051395

2020

SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.

Applications

Unspecified application

Species

Unspecified reactive species

Yifei An,Bo Wang,Xin Wang,Guoying Dong,Jihui Jia,Qing Yang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com